Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8613)
All Articles published online
|
Publishing Process of This Article
|
Aug 16, 2018 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang JZ, Cao HX, Chen JN, Pan Q. PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. World J Clin Cases 2018; 6(8): 167-175 [PMID: 30148144 DOI: 10.12998/wjcc.v6.i8.167] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v6/i8/167.htm |
| Number | Citing Articles |
| 1 |
Yang Yao, Xiangxia Miao, Donglie Zhu, Dongmin Li, Ying Zhang, Chengyan Song, Kaige Liu. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. Endocrine 2019; 65(2): 227 doi: 10.1007/s12020-019-01982-1
|
| 2 |
Meng Chen, Jili Liu, Xin Xia, Yarong Wang, Hongying Zheng. Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1422499
|
| 3 |
Amanda Medeiros Recuero, Larissa Garcia Gomes, Gustavo Arantes Rosa Maciel, Fernanda de Mello Malta, Ana Paula Moreira Salles, Denise Cerqueira Paranaguá Vezozzo, Edmund Chada Baracat, João Renato Rebello Pinho, Flair José Carrilho, José Tadeu Stefano, Claudia P. Oliveira. NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features. Biomedicines 2022; 10(11): 2719 doi: 10.3390/biomedicines10112719
|
| 4 |
Xiao Jing (Iris) Wang, Michael Camilleri. Personalized management in functional gastrointestinal disorders based on genomics: hope at last or just feigned praise?. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756283X18822791
|
| 5 |
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima. Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(6): 1907 doi: 10.3390/ijms21061907
|
| 6 |
Marcello Dallio, Mario Masarone, Mario Romeo, Concetta Tuccillo, Filomena Morisco, Marcello Persico, Carmelina Loguercio, Alessandro Federico. PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.734847
|
| 7 |
Iraklis Perysinakis, Harilaos C. Pappis, Elias Margaris. Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease. Obesity Surgery 2019; 29(3): 1058 doi: 10.1007/s11695-019-03705-x
|
| 8 |
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Andrea Costantino, Gabriele Maffi, Francesca Alletto, Lucia Colavolpe, Paolo Francione, Giovanna Oberti, Erika Fatta, Cristina Bertelli, Giordano Sigon, Paola Dongiovanni, Maurizio Vecchi, Silvia Fargion, Anna Ludovica Fracanzani. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. Nutrients 2022; 14(3): 556 doi: 10.3390/nu14030556
|
| 9 |
Aida Medina-Urrutia, Angel R. Lopez-Uribe, Mohamed El Hafidi, Maria del Carmen González-Salazar, Rosalinda Posadas-Sánchez, Esteban Jorge-Galarza, Leonardo del Valle-Mondragón, Juan G. Juárez-Rojas. Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01283-x
|
| 10 |
O. Yu. Kytikova, T. P. Novgorodtseva, Yu. K. Denisenko, D. A. Kovalevsky. Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 15 doi: 10.22416/1382-4376-2020-30-2-15-25
|
| 11 |
Hsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, Wen-Hui Fang, Chang-Hsien Liu, Jung-Chun Lin, Chih-Weim Hsiang, Kai-Min Chu, Cheng-Huei Hsiong, Guan-Ju Chen, Yung-En Wu, Jia-Yu Hao, Chih-Wen Liang, Oliver Yoa-Pu Hu. Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05686-7
|
| 12 |
Silvia Massami YOSHIMURA, Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Daniel Ferraz de Campos MAZO, João Renato Rebello PINHO, Claudia P OLIVEIRA. PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL. Arquivos de Gastroenterologia 2023; 60(1): 98 doi: 10.1590/s0004-2803.202301000-13
|
| 13 |
Antonella Mosca, Giuseppe Maggiore. Malattia grassa del fegato: tra fattori ambientali e predisposizione genetica. Medico e Bambino 2023; 42(6): 355 doi: 10.53126/MEB42355
|
| 14 |
Kana Daijo, Takashi Nakahara, Yuki Inagaki, Maiko Nanba, Yuno Nishida, Shinsuke Uchikawa, Kenichiro Kodama, Kazuki Oya, Kei Morio, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, C Nelson Hayes, Michio Imamura, Hiroshi Aikata, Hidenori Ochi, Kazuaki Chayama. Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases. Journal of Gastroenterology and Hepatology 2020; 35(8): 1412 doi: 10.1111/jgh.14968
|
| 15 |
Mengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, Dillon C. Gavlock, Richard DeBiasio, Gregory LaRocca, Celeste Reese, Rodrigo M. Florentino, Lanuza A. P. Faccioli, Jacquelyn A. Brown, Lawrence A. Vernetti, Mark Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, Alejandro Soto-Gutierrez, D. Lansing Taylor, Mark T. Miedel. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1423936
|
| 16 |
Elizabeth K. Speliotes, Carolin Victoria Schneider. PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease. Liver International 2024; doi: 10.1111/liv.16106
|
| 17 |
Antonella Mosca, Luca Della Volpe, Maria Rita Sartorelli, Donatella Comparcola, Silvio Veraldi, Anna Alisi, Giuseppe Maggiore. Metabolic Associated Fatty Liver Disease in Children and Adolescents:
Mechanisms of a Silent Epidemic and Therapeutic Options. Current Pediatric Reviews 2024; 20(3): 296 doi: 10.2174/1573396319666230403121805
|
| 18 |
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, Ger H. Koek, Robim M. Rodrigues, Tamara Vanhaecke. PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. Liver International 2023; 43(5): 975 doi: 10.1111/liv.15533
|
| 19 |
Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan M. Pericàs, David Martinez Selva. Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 2022; 10(5): 1015 doi: 10.3390/biomedicines10051015
|
| 20 |
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
|
| 21 |
Nader Salari, Niloufar Darvishi, Kamran Mansouri, Hooman Ghasemi, Melika Hosseinian-Far, Fateme Darvishi, Masoud Mohammadi. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00789-4
|
| 22 |
Yen‐Po Lin, Yu‐Chieh Tsai, Mu Jung Tsai, Pao‐Yuan Huang, Chien‐Hung Chen, Chih‐Chien Yao, Seng‐Kee Chuah, Yuan‐Hung Kuo, Wei‐Chen Tai, Wei‐Shiung Lian, Hsin‐Wei Fang, Tsung‐Hui Hu, Ming‐Chao Tsai. Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals. Advances in Digestive Medicine 2024; 11(3): 129 doi: 10.1002/aid2.13367
|
| 23 |
Melinda H. Spooner, Donald B. Jump. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children. Current Opinion in Clinical Nutrition & Metabolic Care 2019; 22(2): 103 doi: 10.1097/MCO.0000000000000539
|
| 24 |
Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 Pathways. Hepatology 2019; 70(4): 1099 doi: 10.1002/hep.30597
|
| 25 |
Ran Lu, Ye Liu, Tianpei Hong. Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review. Diabetes, Obesity and Metabolism 2023; 25(S1): 13 doi: 10.1111/dom.15014
|
| 26 |
Zobair Younossi, Linda Henry. Non-Alcoholic Fatty Liver Disease. 2020; : 15 doi: 10.1007/978-3-319-95828-6_2
|
| 27 |
Georgios Sfikas, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis, Vasilios G. Athyros. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?. Current Vascular Pharmacology 2021; 19(5): 572 doi: 10.2174/1570161118666201015152921
|
| 28 |
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
|